Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M290Revenue $M114Net Margin (%)-72.4Z-Score-1.7
Enterprise Value $M218EPS $-0.8Operating Margin %-44.4F-Score3
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-72.9Higher ROA y-yY
Price/Book3.510-y EBITDA Growth Rate %0Quick Ratio5.7Cash flow > EarningsY
Price/Sales2.55-y EBITDA Growth Rate %1.8Current Ratio6.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-20.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-68.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M104ROI % (ttm)-46.5Gross Margin Increase y-yN

Gurus Latest Trades with VVUS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VVUSJohn Burbank 2014-06-30 Sold Out -0.23%$4.59 - $6.18
($5.14)
$ 2.79-46%Sold Out0
VVUSJohn Burbank 2014-03-31 Reduce-1.37%$5.6 - $9.55
($7.2)
$ 2.79-61%Reduce -75.95%1,425,000
VVUSJohn Burbank 2013-12-31 Add0.15%$8.235 - $11.19
($9.67)
$ 2.79-71%Add 9.22%5,925,000
VVUSJohn Burbank 2013-09-30 Reduce-1.27%$9.45 - $14.99
($12.54)
$ 2.79-78%Reduce -36.22%5,425,000
VVUSJohn Burbank 2013-06-30 Reduce-0.46%$10.43 - $15.1
($12.91)
$ 2.79-78%Reduce -10.99%8,505,148
VVUSJean-Marie Eveillard 2013-06-30 Sold Out -0.01%$10.43 - $15.1
($12.91)
$ 2.79-78%Sold Out0
VVUSJohn Burbank 2013-03-31 Add0.27%$10.2 - $14.87
($12.43)
$ 2.79-78%Add 6.9%9,554,858
VVUSJean-Marie Eveillard 2013-03-31 Buy 0.01%$10.2 - $14.87
($12.43)
$ 2.79-78%New holding, 200000 sh.200,000
VVUSJohn Burbank 2012-12-31 Add0.8%$10.24 - $22.86
($14.58)
$ 2.79-81%Add 21.15%8,938,268
VVUSGeorge Soros 2012-09-30 Sold Out -0.06%$17.81 - $29.93
($23.45)
$ 2.79-88%Sold Out0
VVUSJohn Burbank 2012-06-30 Add0.73%$21.5 - $28.68
($24.02)
$ 2.79-88%Add 10.12%8,136,600
VVUSGeorge Soros 2012-06-30 Reduce-0.09%$21.5 - $28.68
($24.02)
$ 2.79-88%Reduce -64.93%150,000
VVUSJohn Burbank 2012-03-31 Add2.35%$9.99 - $23.78
($14.83)
$ 2.79-81%Add 72.22%7,388,793
VVUSGeorge Soros 2012-03-31 Buy 0.14%$9.99 - $23.78
($14.83)
$ 2.79-81%New holding, 427750 sh.427,750
VVUSGeorge Soros 2011-03-31 Sold Out $6.06 - $11.2
($7.95)
$ 2.79-65%Sold Out0
VVUSGeorge Soros 2010-12-31 Buy $5.94 - $9.78
($7.38)
$ 2.79-62%New holding, 19400 sh.19,400
VVUSDaniel Loeb 2010-06-30 Sold Out -0.62%$8.71 - $13.2
($10.68)
$ 2.79-74%Sold Out0
VVUSDaniel Loeb 2010-03-31 Buy 0.62%$8.24 - $10.54
($9.06)
$ 2.79-69%New holding, 1000000 sh.1,000,000
VVUSLee Ainslie 2008-12-31 Sold Out -0.01%$4.75 - $6.64
($5.7)
$ 2.79-51%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VVUS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


VVUS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sanford Svai SCFO & Chief Accounting Officer 2015-01-29Sell472$2.783.24view
MARSH GUY PVP, US Operations & GM 2015-01-29Sell238$2.783.24view
Slebir John LSVP, Business Development & GC 2015-01-29Sell630$2.783.24view
Day WesleyVP, Clinical Development 2015-01-29Sell472$2.783.24view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-08Buy500,000$3.12-8.01view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-06Buy476,800$3.04-5.59view
NORTH TIDE CAPITAL, LLC10% Owner 2015-01-02Buy523,200$2.9-1.03view
Fischer Seth H.Z.CEO 2014-03-11Buy3,080$6.07-52.72view
DENNER ALEXANDER JDirector 2013-11-11Buy566,844$8.59-66.59view
MORRIS TIMOTHY EVP, Finance and CFO 2013-09-05Sell10,654$11.95-75.98view

Press Releases about VVUS :

    Quarterly/Annual Reports about VVUS:

    News about VVUS:

    Articles On GuruFocus.com
    5-year lows: Vivus, Synta Pharmaceuticals Inc, MVC Capital Inc, and Kemet Corp. Feb 08 2015 
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Weekly Three-Year Low Highlight: VVUS, RALY, WILN, COVS Mar 25 2014 
    Billionaires Hold Four Stocks, 59% Off Sep 30 2013 
    Unique Investor Kyle Bass Unloads Five May 29 2013 
    Weekly Guru Bargains Highlights: FTE, VVUS, PAY, TIBX, VMW Feb 24 2013 
    Weekly Guru Bargains Highlights: FTNT, VVUS, HAE, PC, TIBX Dec 09 2012 
    Weekly Guru Bargains Highlights: CIG, PWE, VVUS, EBR, ATHN Dec 03 2012 
    Passport’s John Burbank Boosts VIVUS Stake to 8.5 Pct of Company Nov 02 2012 
    Weekly Top Insider Buys: IRM, JCP, APU, CAB, VVUS Aug 27 2012 


    More From Other Websites
    Nasdaq backs off from 5,000 Mar 03 2015
    Orexigen Soars On Obesity Drug's Surprise Health Boon Mar 03 2015
    Orexigen Weight-Loss Pill Shows Surprise Heart-Safety Benefit Mar 03 2015
    10-K for VIVUS, Inc. Feb 27 2015
    Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog Feb 26 2015
    JPM Securities Picks Through Biotech News For Winners Feb 25 2015
    VIVUS Q4 Loss Wider than Expected, Qsymia Disappoints - Analyst Blog Feb 25 2015
    Vivus reports 4Q loss Feb 24 2015
    Vivus reports 4Q loss Feb 24 2015
    VIVUS Inc Earnings Call scheduled for 4:30 pm ET today Feb 24 2015
    VIVUS Reports Fourth Quarter and Year-End 2014 Financial Results Feb 24 2015
    VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 24 2015
    Q4 2014 Vivus Inc Earnings Release - After Market Close Feb 24 2015
    Obesity Drugs: Orexigen Gains Market Share at Expense of Arena, Vivus Feb 20 2015
    Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
    VIVUS to Present at Upcoming Investor Conference Feb 20 2015
    VIVUS to Present at Upcoming Investor Conference Feb 20 2015
    VIVUS Announces Date of Fourth Quarter and Year End 2014 Update and Financial Results Conference... Feb 19 2015
    VIVUS Announces Date of Fourth Quarter and Year End 2014 Update and Financial Results Conference... Feb 19 2015
    VIVUS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 29 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK